US Supreme Court rejects bid to restrict access to abortion pill mifepristone
Americans will still be able to buy an abortion pill after the US Supreme Court threw out a bid by campaign groups to restrict access to it.
The decision was made by the same court that two years ago overturned Roe v Wade – which had previously given women rights to terminate a pregnancy.
The drug – mifepristone – was first approved by the Food and Drug Administration (FDA) in September 2000 for medical termination up to seven weeks into pregnancy, extended to 10 weeks in 2016.
It was ruled the plaintiffs behind the lawsuit challenging mifepristone lacked the necessary legal standing to pursue the case, which required they show they have been harmed in a way that can be traced to the FDA.
The plaintiffs wanted an end to rules introduced in 2016 and 2021 that permitted medication abortions at up to 10 weeks of pregnancy instead of seven, and for mail delivery of the drug without a woman first seeing a doctor in-person.
The suit initially had sought to reverse FDA approval of mifepristone, but that aspect was thrown out by a lower court.
Mifepristone is taken with another drug called misoprostol to perform medication abortions – now the most common method of terminating pregnancies in the US.
Read more: Why were there calls to ban abortion drug?
Anti-abortion activists outside the Supreme Court in April 2023. Pic: Reuters
The FDA said that after decades of use by millions of women in the US and around the world, mifepristone has proven “extremely safe” and that studies have demonstrated that “serious adverse events are exceedingly rare”.
The plaintiffs, known as the Alliance for Hippocratic Medicine, argued the FDA acted contrary to its mandate to ensure medications are safe when it eased the restrictions on mifepristone.
They also accused the administration of violating a federal law governing the actions of regulatory agencies.
US District Judge Matthew Kacsmaryk broadly sided with them in a 2023 decision that would have effectively pulled the pill off the market.
Read more on Sky News:
What’s changed since Roe v Wade decision was overturned?
However, after the FDA appealed, the New Orleans-based 5th US Circuit Court of Appeals did not go as far as Kacsmaryk but still ruled against its move to widen access to the pill.
This decision was placed on hold pending the Supreme Court’s review.
The plaintiffs said they had legal standing to sue because their member doctors would be forced to violate their consciences due to “often be called upon to treat abortion-drug complications” in emergency settings.
The Justice Department said these claims relied on an impermissibly speculative chain of events.
Following the decision, Joe Biden said in a statement: “Today’s decision does not change the fact that the fight for reproductive freedom continues.
“It does not change the fact that the Supreme Court overturned Roe v Wade two years ago, and women lost a fundamental freedom.
“It does not change the fact that the right for a woman to get the treatment she needs is imperiled if not impossible in many states.”
Keep up with all the latest news from the UK and around the world by following Sky News
Meanwhile, Mr Trump – speaking at a campaign event – acknowledged the issue had cost Republicans and that it is too important to ignore.
The presidential hopeful said it was his preference for the decision to be made by the people and individual states.
The mifepristone dispute is not the only abortion case the Supreme Court is due to decide during this presidential election year.
It also is expected to rule by the end of June on the legality of Idaho’s strict Republican-backed abortion ban that forbids terminating a pregnancy even if necessary to protect the health of a pregnant woman facing a medical emergency.
Vladimir Putin told Donald Trump he “will not back down” from Russia’s goals in Ukraine during a phone call today, the Kremlin has said.
The Russian president spoke to his US counterpart for almost an hour, and Mr Trump “again raised the issue of an early end to military action” in Ukraine, Kremlin aide Yuri Ushakov told reporters.
In response, Mr Putin said “Russia will not back down” from its aims there, which include “the elimination of the well-known root causes that led to the current state of affairs,” Mr Ushakov said.
The phrase “root causes” is shorthand for Moscow’s argument that it was compelled to invade Ukraine in order to prevent the country from joining NATO.
Please use Chrome browser for a more accessible video player
Trump and Putin’s latest call on Ukraine
Ukraine and its European allies say this is a pretext to justify what they call an imperial-style war, but Mr Trump has previously shown sympathy with Russia.
At the same time, Mr Putin told the US president that Russia is ready to continue negotiating, the aide said.
The Russian president said any prospective peace deal must see Ukraine give up its NATO bid and recognise his country’s territorial gains.
Volodymyr Zelenskyy, seen with Mr Trump in June, is pushing for Ukraine to join NATO. Pic: Reuters
He also briefed Mr Trump on agreements made last month, which saw Russia and Ukraine exchange prisoners of war and dead soldiers.
Specific dates for the third round of peace talks in Istanbul were not discussed – nor was the US decision to halt some shipments of critical weapons to Ukraine.
Mr Putin and Mr Trump’s call came after the Pentagon confirmed some weapons due to be sent to Ukraine have been held as it reviews military stockpiles.
The paused shipments include air defence missiles and precision-guided artillery, two people familiar with the situation have said.
Read more:
Putin threatens nuclear strike
Western brands on Russian shelves despite sanctions
Listen to The World with Richard Engel and Yalda Hakim every Wednesday
The decision led to Ukraine calling in the acting US envoy to Kyiv on Wednesday to underline the importance of military aid from Washington.
Kyiv also cautioned that the move would weaken Ukraine’s ability to defend itself against intensifying Russian airstrikes and battlefield advances.
Mr Putin and Mr Trump’s phone call was the sixth they have publicly disclosed since the US president returned to the White House in January.
Donald Trump’s ‘big beautiful bill’ has been passed by the US congress, sending it to the president to sign into law.
The controversial tax breaks and spending cuts package cleared its final hurdle as the Republican-controlled House of Representatives narrowly approved the bill with a 218-214 vote.
The bill delivers tax breaks Mr Trump promised in his 2024 election campaign, cuts health and food safety programmes, and zeroes out dozens of green energy incentives.
According to the nonpartisan Congressional Budget Office (CBO), it will lower tax revenues by $4.5trn over 10 years and add $3.4trn to the US’s $36.2trn debt.
But despite concerns over the 869-page bill’s price tag – and its hit to healthcare programmes – Republicans largely lined up in support, with just two rebelling on the vote.
House Speaker Mike Johnson is congratulated following the vote. Pic: Reuters
Every Democrat in Congress voted against the bill, blasting it as a giveaway to the wealthy that will leave millions of Americans uninsured.
House Speaker Mike Johnson made the Republicans’ closing argument for the bill, telling Congress: “For everyday Americans, this means real, positive change that they can feel.”
Earlier, the House’s Democratic leader Hakeem Jeffries gave a record-breaking eight-hour and 44-minute speech against it.
“The focus of this bill, the justification for all of the cuts that will hurt everyday Americans, is to provide massive tax breaks for billionaires,” he said.
👉 Follow Trump100 on your podcast app 👈
The bill’s spending cuts largely target Medicaid, the health programme that covers 71 million Americans on low incomes.
It will tighten enrolment standards, institute a work requirement and clamp down on a funding mechanism used by states to boost federal payments.
The changes could leave nearly 12 million people without health insurance, according to the CBO.
On the other side of the ledger, it will stave off tax increases that were due to hit most Americans at the end of the year, when tax cuts from President Trump’s first term were due to expire.
It also sets up new tax breaks for overtime pay, seniors and tipped income.
Read more:
Why the bill sparked an ugly debate
Kremlin shares details of Putin-Trump call
The bill narrowly passed the US Senate on Tuesday after vice president JD Vance cast the deciding vote to break a 50-50 tie.
Mr Trump will sign it into law on Friday at 5pm local time (10pm in the UK), the White House said.
-
Sports3 years ago‘Storybook stuff’: Inside the night Bryce Harper sent the Phillies to the World Series
-
Sports1 year agoStory injured on diving stop, exits Red Sox game
-
Sports2 years agoGame 1 of WS least-watched in recorded history
-
Sports2 years agoMLB Rank 2023: Ranking baseball’s top 100 players
-
Sports4 years ago
Team Europe easily wins 4th straight Laver Cup
-
Environment2 years agoJapan and South Korea have a lot at stake in a free and open South China Sea
-
Sports2 years agoButton battles heat exhaustion in NASCAR debut
-
Environment2 years agoGame-changing Lectric XPedition launched as affordable electric cargo bike